Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
US10421765B2 · kind B2 · utility
6Cited by
0References
39Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 25, 2018 |
| Grant date | Sep 24, 2019 |
| Priority date | — |
| Expiry date | May 25, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/18
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to tetrahydropyrido[4,3-d]pyrimidine based compounds and methods which may be useful as inhibitors of ATR kinase for the treatment or prevention of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.